Nuclear p65 expression (Nuc-p65) was detected in control BC-3 cells, but this was reduced in DDTC-treated BC-3 cells at 12 h of treatment and returned to basal level at 24 h of treatment (Fig. 2A; Nuc-p65). Here, NUCB1 is linked to breast cancer.